ACM
ALPN

Atika Capital Management’s Alpine Immune Sciences Inc ALPN Stock Holding History

Atika Capital Management’s Portfolio ALPN Stock Details ALPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-256,000
Closed -$10.1M – 121
2024
Q1 		$10.1M Buy
+256,000
New +$7.55M 1% 40

Atika Capital Management's ALPN Position: Q2 2024 in Review

Atika Capital Management sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 256,000 shares — an estimated $10.1M sold.

Atika Capital Management first reported a position in ALPN in Q1 2024 and held it in 1 quarter. The position peaked at $10.1M in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

  • Atika Capital Management reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
  • Atika Capital Management sold 256,000 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $10.1M.
  • Atika Capital Management first reported a position in Alpine Immune Sciences Inc in Q1 2024 and held it in 1 quarter.
  • Atika Capital Management's Alpine Immune Sciences Inc position peaked at $10.1M in Q1 2024.
  • 0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on Atika Capital Management's 13F filing for Q2 2024, filed 13 Aug 2024.